These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31013221)

  • 41. Imipenem-cilastatin sodium, a broad-spectrum carbapenem antibiotic combination.
    Pastel DA
    Clin Pharm; 1986 Sep; 5(9):719-36. PubMed ID: 3530614
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Imipenem/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients].
    Pérez C; Sirham M; Labarca J; Grebe G; Lira P; Oliva J; Duhalde M; Ocqueteau M; Acuña G
    Rev Med Chil; 1995 Mar; 123(3):312-20. PubMed ID: 8525170
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam.
    Jellison TK; Mckinnon PS; Rybak MJ
    Pharmacotherapy; 2001 Feb; 21(2):142-8. PubMed ID: 11213849
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections.
    Sims M; Mariyanovski V; McLeroth P; Akers W; Lee YC; Brown ML; Du J; Pedley A; Kartsonis NA; Paschke A
    J Antimicrob Chemother; 2017 Sep; 72(9):2616-2626. PubMed ID: 28575389
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exposure to imipenem/cilastatin causes nephrotoxicity and even urolithiasis in Wistar rats.
    Tahri A; Lahyani A; Kallel R; Ayadi F; Boudawara T; Sahnoun Z
    Toxicology; 2018 Jul; 404-405():59-67. PubMed ID: 29775647
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of Imipenem/Cilastatin Burn Intensive Care Unit Patients Undergoing High-Dose Continuous Venovenous Hemofiltration.
    Boucher BA; Hudson JQ; Hill DM; Swanson JM; Wood GC; Laizure SC; Arnold-Ross A; Hu ZY; Hickerson WL
    Pharmacotherapy; 2016 Dec; 36(12):1229-1237. PubMed ID: 27862103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Efficacy and tolerance of imipenem/cilastatin in the treatment of surgical infections with and without bone involvement].
    Voeckl J; Fischer M
    Infection; 1986; 14 Suppl 2():S154-9. PubMed ID: 3759250
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Imipenem: a new carbapenem antibiotic.
    Lipman B; Neu HC
    Med Clin North Am; 1988 May; 72(3):567-79. PubMed ID: 3280907
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Monotherapy, empirical and targetted, with imipenem-cilastatin in sepsis of bacterial origin].
    Fiorentino F; De Sena R; Manzillo E; Iadanza A; Conte M; Coppola MG; Galderisi P; Postiglione A; Arciello MT; Covelli B
    Clin Ter; 1989 May; 129(4):287-91. PubMed ID: 2527122
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A post hoc subgroup analysis of meropenem versus imipenem/cilastatin in a multicenter, double-blind, randomized study of complicated skin and skin-structure infections in patients with diabetes mellitus.
    Embil JM; Soto NE; Melnick DA
    Clin Ther; 2006 Aug; 28(8):1164-1174. PubMed ID: 16982293
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of antipseudomonal β-lactams for febrile neutropenia empiric therapy: systematic review and network meta-analysis.
    Horita N; Shibata Y; Watanabe H; Namkoong H; Kaneko T
    Clin Microbiol Infect; 2017 Oct; 23(10):723-729. PubMed ID: 28377312
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study.
    Sanz MA; Bermúdez A; Rovira M; Besalduch J; Pascual MJ; Nocea G; Sanz-Rodríguez C;
    Curr Med Res Opin; 2005 May; 21(5):645-55. PubMed ID: 15969864
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Elevated plasma cysteinylglycine levels caused by cilastatin-associated antibiotic treatment.
    Badiou S; Bellet H; Lehmann S; Cristol JP; Jaber S
    Clin Chem Lab Med; 2005; 43(3):332-4. PubMed ID: 15843241
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of inhaled imipenem/cilastatin in pediatric patients with cystic fibrosis: A case series.
    Jones LA; Doucette L; Dellon EP; Esther CR; McKinzie CJ
    J Cyst Fibros; 2019 Jul; 18(4):e42-e44. PubMed ID: 31060800
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Imipenem/cilastatin drug utilization evaluation in a large community hospital.
    Sesin GP
    DICP; 1991 Dec; 25(12):1399. PubMed ID: 1815448
    [No Abstract]   [Full Text] [Related]  

  • 56. [Invasive Campylobacter jejuni/coli Infections: 9 Case Reports at a Single Center between 2000 and 2015, and a Review of Literature Describing Japanese Patients].
    Tasaka K; Matsubara K; Nigami H; Iwata A; Isome K; Yamamoto G
    Kansenshogaku Zasshi; 2016 May; 90(3):297-304. PubMed ID: 27529964
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and tolerability of imipenem-cilastatin versus ceftazidime plus tobramycin as empiric therapy of presumed bacterial infection in neutropenic cancer patients.
    Miller JA; Butler T; Beveridge RA; Kales AN; Binder RA; Smith LJ; Ueno WM; Milkovich G; Goldwater S; Marion A
    Clin Ther; 1993; 15(3):486-99. PubMed ID: 8364941
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A randomized prospective study of imipenem-cilastatin with or without amikacin as an empirical antibiotic treatment for febrile neutropenic patients.
    Kojima A; Shinkai T; Soejima Y; Okamoto H; Eguchi K; Sasaki Y; Tamura T; Oshita F; Ohe Y; Saijo N
    Am J Clin Oncol; 1994 Oct; 17(5):400-4. PubMed ID: 8092111
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Levofloxacin in the empirical treatment of patients with suspected bacteraemia/sepsis: comparison with imipenem/cilastatin in an open, randomized trial.
    Geddes A; Thaler M; Schonwald S; Härkönen M; Jacobs F; Nowotny I
    J Antimicrob Chemother; 1999 Dec; 44(6):799-810. PubMed ID: 10590282
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drugs recently released in Belgium. Torasemide, nalbuphine, imipenem-cilastatin.
    Harvengt C
    Acta Clin Belg; 1987; 42(4):298-302. PubMed ID: 3270973
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.